The estimated Net Worth of Jean Marc Huet is at least $1.21 Milión dollars as of 30 April 2009. Jean Huet owns over 25,000 units of Bristol-Myers Squibb Co stock worth over $1,214,750 and over the last 16 years Jean sold BMY stock worth over $0.
Jean has made over 1 trades of the Bristol-Myers Squibb Co stock since 2009, according to the Form 4 filled with the SEC. Most recently Jean bought 25,000 units of BMY stock worth $481,250 on 30 April 2009.
The largest trade Jean's ever made was buying 25,000 units of Bristol-Myers Squibb Co stock on 30 April 2009 worth over $481,250. On average, Jean trades about 8,333 units every 0 days since 2009. As of 30 April 2009 Jean still owns at least 25,000 units of Bristol-Myers Squibb Co stock.
You can see the complete history of Jean Huet stock trades at the bottom of the page.
Jean's mailing address filed with the SEC is BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 & PROVINCELINE ROAD, PRINCETON, NJ, 08543.
Over the last 17 years, insiders at Bristol-Myers Squibb Co have traded over $318,151,721 worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth $6,601,565 . The most active insiders traders include Lamberto Andreotti, James M Cornelius a Giovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of $1,682,720. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth $51,554.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: